Prevalence and natural history of adrenal incidentalomas

European Journal of Endocrinology

Volumn 149, Issue 4, 2003, Pages 273-285

  Barzon, Luisa ^a   Sonino, Nicoletta ^a   Fallo, Francesco ^a   Palù, Giorgio ^a   Boscaro, Marco ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; AGED; AUTOPSY; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER RISK; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HISTOLOGY; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE RELEASE; HYPERADRENOCORTICISM; INCIDENCE; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; TUMOR VOLUME;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENAL HYPERPLASIA, CONGENITAL; AGE FACTORS; CUSHING SYNDROME; HUMANS; HYDROCORTISONE; RISK FACTORS; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0142154265     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490273     Document Type: Review

References (127)

1. Kloos RT, Gross MD, Francis IR, Korobkin M & Shapiro B. Incidentally discovered adrenal masses. Endocrine Reviews 1995 16 460-484.
2. Grumbach MM, Biller MK, Braunstein GD, Campbell KK, Carney JA, Godley PA et al. Management of the clinically inapparent adrenal mass ('incidentaloma'). Annals of Internal Medicine 2003 138 424-429.
3. Rineheart JF, Williams OO & Cappeller WS. Adenomatous hyperplasia of the adrenal cortex associated with essential hypertension. Archives of Pathology 1941 34 1031-1034.
4. Russi S, Blumenthal HT & Gray SH. Small adenomas of the adrenal cortex in hypertension and diabetes. Archives of Internal Medicine 1945 76 284-291.
5. Commons RR & Callaway CP. Adenomas of the adrenal cortex. Archives of Internal Medicine 1948 81 37-41.
6. Schroeder HA. Clinical types - the endocrine hypertensive syndrome. In Hypertensive Diseases: Causes and Control, pp 295-333. Ed. HA Schroeder. Philadelphia: Lea & Febiger, 1953.
7. Devenyi I. Possibility of normokalaemic primary aldosteronism as reflected in the frequency of adrenal cortical adenomas. Journal of Clinical Patholology 1967 20 49-51.
8. Kokko JP, Brown TC & Berman MM. Adrenal adenoma and hypertension. Lancet 1967 1 468-470.
9. Hedeland H, Ostberg G & Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Medica Scandinavica 1968 184 211-214.
10. Yamada EY & Fukunaga FH. Adrenal adenoma and hypertension. A study in the Japanese in Hawaii. Japanese Heart Journal 1969 10 11-19.
11. Granger P & Genest J. Autopsy study of adrenal in unselected normotensive and hypertensive patients. Canadian Medical Association Journal 1970 103 34-36.
12. Russell RP, Masi AT & Ritcher ED. Adrenal cortical adenomas and hypertension. A clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine 1972 51 211-225.
13. Abecassis M, McLoughlin MJ, Langer B & Kudlow JE. Serendipitous adrenal masses: prevalence, significance, and management. American Journal of Surgery 1985 149 783-788.
14. Meagher AP, Hugh TB, Casey JH, Chisholm DJ, Farrell JC & Yates M. Primary adrenal tumors - a ten years experience. Australian and New Zealand Journal of Surgery 1988 58 457-462.
15. Reinhard C, Saeger W & Schubert B. Adrenocortical nodules in post-mortem series, Development, functional significance, and differentiation from adenomas. General and Diagnostic Pathology 1996 141 203-208.
16. Aso Y & Homma Y. A survey on incidental adrenal tumors in Japan. Journal of Urology 1992 147 1478-1481.
17. Glazer HS, Weyman PJ, Sagel SS, Levitt RG & McClennan BL. Nonfunctioning adrenal masses: incidental discovery on computed tomography. American Journal of Roentgenology 1982 139 81-85.
18. Prinz RA, Brooks MH, Churchill R, Graner JL, Lawrence AM, Paloyan E, Sparagana M et al. Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required? Journal of the American Medical Association 1982 248 701-704.
19. Belldegrun A, Hussain S, Seltzer SE, Loughlin KR, Gittes RF & Richie JP. Incidentally discovered mass of the adrenal gland. Surgery Gynecology and Obstetrics 1986 163 203-208.
20. Herrera MF, Grant CS, van Heerden JA, Sheedy PF & Ilstrup DM. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991 110 1014-1021.
21. Caplan RH, Strutt PJ & Wickus GG. Subclinical hormone secretion by incidentally discovered adrenal masses. Archives of Surgery 1994 129 291-296.
22. Francis IR, Smid A, Gross MD, Shapiro B, Naylor B & Glazer GM. Adrenal masses in oncologic patients: functional and morphologic evaluation. Radiology 1988 166 353-356.
23. Lam KY & Lo CY. Metastatic tumors of the adrenal glands: a 30 years experience in a teaching hospital. Clinical Endocrinology 2002 56 95-101.
24. Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abbruzzese MC et al. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 1998 124 1115-1122.
25. Hess KR, Abbruzzese MC, Lenzi R, Raber MN & Abbruzzese JL. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clinical Cancer Research 1999 5 3403-3410.
26. Hemminki K & Jiang Y. Second primary neoplasms after 19281 endocrine gland tumors: aetiological links? European Journal of Cancer 2001 37 1886-1894.
27. Skogseid B, Larsson C, Lindgren P, Kvanta E, Rastad J, Theodorsson E et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism 1992 75 76-81.
28. Burgess JR, Harle RA, Tucker P, Parameswaran V, Davies P, Greenaway TM et al. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Archives of Surgery 1996 131 699-702.
29. Barzon L, Pasquali C, Grigoletto C, Pedrazzoli S, Boscaro M & Fallo F. Multiple endocrine neoplasia type 1 and adrenal lesions. Journal of Urology 2001 166 24-27.
30. Neumann H, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. New England Journal of Medicine 1993 329 1531-1538.
31. Dluhy RG. Pheochromocytoma - death of an axiom. New England Journal of Medicine 2002 346 1486-1488.
32. Aprill BS, Drake AJ, Lasseter DH & Shakir M. Silent adrenal nodules in von Hippel-Lindau disease suggest pheochromocytoma. Annals of Internal Medicine 1994 120 485-487.
33. Neumann H, Baucsh B, McWhinney SR, Bender BU, Gimm O, Franke G et al. Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 2002 346 1459-1466.
34. Walther MM, Herring J, Enquist E, Keiser HR & Linehan WM. von Recklinghausen's disease and pheochromocytomas. Journal of Urology 1999 162 1582-1586.
35. Stratakis CA, Kirschner LS & Carney JA. Clinical and molecular features of the Carney Complex: diagnostic criteria and recommendations for patient evaluation. Journal of Clinical Endocrinology and Metabolism 2001 86 4041-4046.
36. Varley JM, Evans DG & Birch JM. Li-Fraumeni syndrome - a molecular and clinical review. British Journal of Cancer 1997 76 1-14.
37. Marchesa P, Fazio VW, Church JM & McGannon E. Adrenal masses in patients with familial adenomatous polyposis. Diseases of the Colon and Rectum 1997 40 1023-1028.
38. Smith TG, Clark SK, Katz DE, Reznek RH & Philips RK. Adrenal masses are associated with familial adenomatous polyposis. Diseases of the Colon and Rectum 2000 43 1739-1742.
39. Wiedemann HR, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ & Schirg E. The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. European Journal of Pediatrics 1983 140 5-12.
40. Ravichandran R, Lafferty F, McGinniss MJ & Taylor HC. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1996 81 1776-1779.
41. Nagasaka S, Kubota K, Motegi T, Hayashi E, Ohta M, Takahashi K et al. A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma. Clinical Endocrinology 1996 44 111-116.
42. Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macri C et al. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. Journal of Clinical Endocrinology and Metabolism 1998 83 55-62.
43. Kacem M, Said M, Achour L, Hadj Youssef F, Ben Kacem S, Mahjoub S et al. Large bilateral adrenal incidentalomas complicating untreated 11B hydroxylase deficiency in the third decade of life. A case report. Annales d'Endocrinologie 2000 61 418-421.
44. Kjellman M, Holst M, Backdahl M, Larsson C, Farnebo L-O & Wedell A. No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours. Clinical Endocrinology 1999 50 343-346.
45. Beuschlein F, Schulze E, Mora P, Gensheimer HP, Maser-Gluth C, Allolio B et al. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 2585-2588.
46. Maser-Gluth C, Reinke M, Allolio B & Schulze E. Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas. European Journal of Clinical Investigation 2000 30 83-86.
47. Jaresch S, Kornely E, Kley HK & Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1992 74 685-689.
48. Sadoul JL, Kezachian B, Altare S, Hadjali Y & Canivet B. Apparent activities of 21-hydroxylase, 17alpha-hydroxylase and 17,20-lyase are impaired in adrenal incidentalomas. European Journal of Endocrinology 1999 141 238-245.
49. Toth M, Racz K, Adleff V, Varga I, Futo L, Jakab C et al. Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy. Journal of Endocrinological Investigation 2000 23 287-294.
50. Dall'Asta C, Barbetta L, Libe R, Passini E & Ambrosi B. Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome. Hormone Research 2002 57 192-196.
51. Ambrosi B, Peverelli S, Passini E, Re T, Ferrario R, Colombo P et al. Abnormalities of endocrine function in patients with clinically 'silent' adrenal masses. European Journal of Endocrinolology 1995 132 422-428.
52. 131I-Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clinical Endocrinology 1996 44 587-596.
53. Barzon L, Fallo F, Sonino N & Boscaro M. Development of overt Cushing's syndrome in patients with adrenal incidentalomas. European Journal of Endocrinology 2002 146 61-66.
54. Bastounis EA, Karayiannakis AJ, Anapliotou MLG, Nakopoulou L, Makri GG & Papalambros EL. Incidentalomas of the adrenal gland: diagnostic and therapeutic implications. American Surgeon 1997 63 356-360.
55. Bencsik Z, Szabolcs I, Goth M, Voros A, Kaszas I, Gonczi J et al. Incidentally detected adrenal tumors (incidentalomas): histological heterogeneity and differential therapeutic approach. Journal of Internal Medicine 1995 237 585-589.
56. Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P et al. Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 1997 46 107-113.
57. Bulow B & Ahren B. Adrenal incidentaloma - experience of a standardized diagnostic programme in the Swedish prospective study. Journal of Internal Medicine 2002 252 239-246.
58. Favia G, Lumachi F, Basso S & D'Amico DF. Management of incidentally discovered adrenal masses and risk of malignancy. Surgery 2000 128 918-924.
59. Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G et al. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumor. Clinical Endocrinology 1995 42 129-134.
60. Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J, Tolloczko T, Szamowska R, Leowska E et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clinical Endocrinology 1997 46 29-37.
61. Linos DA, Stylopoulos N & Raptis SA. Adrenaloma: a call for a more aggressive management. World Journal of Surgery 1996 20 788-793.
62. Mantero F & Arnaldi G. Management approaches to adrenal incidentalomas: a view from Ancona, Italy. Endocrinology and Metabolism Clinics of North America 2000 29 107-111.
63. Murai M, Baba S, Nakashima J & Tachibana M. Management of incidentally discovered adrenal masses. World Journal of Urology 1999 17 9-14.
64. Osella G, Terzolo M, Borretta G, Magro G, Ali A, Piovesan A et al. Endocrine evaluation of incidentally discovered adrenal masses. Journal of Clinical Endocrinology and Metabolism 1994 79 1532-1539.
65. Proye C, Jafari Manjili M, Combemale F, Pattou F, Ernst O, Carnaille B et al. Experience gained from operation of 103 adrenal incidentalomas. Langenbeck's Archives of Surgery 1998 383 330-333.
66. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B & Wienkelmann W. Preclinical Cushing's syndrome in adrenal 'incidentalomas': comparison with adrenal Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1992 75 826-832.
67. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism 2000 85 1440-1448.
68. Seppel T & Schlaghecke R. Augmented 14α-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas'). Clinical Endocrinology 1994 41 445-451.
69. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A et al. A survey on adrenal incidentaloma in Italy. Journal of Clinical Endocrinology and Metabolism 2000 85 637-644.
70. Tanabe A, Naruse M, Nishikawa T, Yoshimoto T, Shimizu T, Seki T et al. Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Hormone and Metabolic Research 2001 33 444-450.
71. Terzolo M, Ali A, Osella G & Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Archives of Surgery 1997 132 914-919.
72. Tutuncu NB & Gedik O. Adrenal incidentaloma: report of 33 cases. Journal of Surgical Oncology 1999 70 247-250.
73. Virkkala A, Valimaki M, Pelkonen R, Huikuri K, Kahri A, Kivisaari L et al. Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. Acta Endocrinologica 1989 121 67-72.
74. Linos DA & Stylopoulos N. How accurate is computed tomograpy in predicting the real size of adrenal tumors? Archives of Surgery 1997 132 740-743.
75. Ichijo T, Ueshiba H, Yakushiji F, Nakamura T & Miyachi Y. A survey on adrenal incidentalomas in Japan. Proceedings of the 84th Meeting of the Endocrine Society Abstract OR25-4. 2002.
76. Barzon L & Boscaro M. Diagnosis and management of adrenal incidentalomas. Journal of Urology 2000 163 398-407.
77. Fallo F, Barzon L, Boscaro M & Sonino N. Coexistence of aldosteronoma and contralateral nonfunctioning adrenal adenoma in primary aldosteronism. American Journal of Hypertension 1997 10 476-478.
78. Morimoto S, Sasaki S, Moriguchi J, Miki S, Kawa T, Nakamura K et al. Unique association of pheochromocytoma with contralateral nonfunctioning adrenal cortical adenoma. American Journal of Hypertension 1998 11 117-121.
79. Satoh F, Murakami O, Takahashi K, Ueno J. Nishikawa T, Abe K et al. Double adenomas with different pathological and hormonal features in the left adrenal gland of a patient with Cushing's syndrome. Clinical Endocrinology 1997 46 227-234.
80. Bourdeau I, D'Amour P, Hamet P, Boutin J-M & Lacroix A. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 5534-5540.
81. Charbonnel B, Chatal JF & Ozanne P. Does the corticoadrenal adenoma with pre-Cushing's syndrome exist? Journal of Nuelear Medicine 1981 22 1059-1061.
82. Reincke M. Subclinical Cushing's syndrome. Endocrinology and Metabolism Clinics of North America 2000 29 42-56.
83. Hensen J, Buhl M, Bahr V & Oelkers W. Endocrine activity of the 'silent' adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Klinische Wochenschrift 1990 68 608-614.
84. McLeod MK, Thompson NW, Gross MD, Bondeson AG & Bondeson L. Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. American Surgeon 1990 56 398-403.
85. Siren J, Haapiainen R, Huikuri K & Sivula A. Incidentalomas of the adrenal gland: 36 operated patients and review of literature. World Journal of Surgery 1993 17 634-639.
86. Fernandez-Real JM, Richart Engel W & Simò R. Pre-clinical Cushing's syndrome: Report of three cases and literature review. Hormone Research 1994 41 230-235.
87. Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P et al. Subclinical Cushing's syndrome in adrenal incidentaloma. Clinical Endocrinology 1998 48 89-97.
88. Morioka M, Fujii T, Matsuki T, Jo Y, Kobayashi T, Tanaka H et al. Preclinical Cushing's syndrome: report on seven cases and review of the literature. International Journal of Urology 2000 7 126-132.
89. Midorikawa S, Sanada H, Hashimoto S, Suzuki T & Watanabe T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clinical Endocrinology 2001 54 797-804.
90. Grossrubatscher E, Vignati F, Possa M & Loli P. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation. Journal of Endocrinological Investigation 2001 24 846-855.
91. Lavoie H & Lacroix A. Partially autonomous cortisol secretion by incidentally discovered adrenal adenomas. Trends in Endocrinology and Metabolism 1995 6 191-197.
92. Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Ferriere JM et al. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. European Journal of Endocrinology 2001 144 401-408.
93. Barzon L, Fallo F, Sonino N & Boscaro M. Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas. European Journal of Endocrinology 2001 144 223-224.
94. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C & Thalassinos N. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clinical Endocrinology 1998 48 165-171.
95. Bernini GP, Moretti A, Argenio G & Salvetti A. Primary aldosteronism in normokalemic patients with adrenal incidentalomas. European Journal of Endocrinology 2002 146 523-529.
96. Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocrine Reviews 1994 15 356-368.
97. Sutton MG, Sheps SG & Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clinic Proceedings 1981 56 354-360.
98. Bernini GP, Vivaldi MS, Argenio GF, Moretti A, Sgro M & Salvetti A. Frequency of pheochromocytoma in adrenal incidentalomas and utility of the glucagon test for the diagnosis. Journal of Endocrinological Investigation 1997 20 65-71.
99. Mannelli M, Ianni L, Cilotti A & Conti A. Pheochromocytoma in Italy: a multicentric retrospective study. European Journal of Endocrinology 1999 141 619-624.
100. Kudva YC, Young WF Jr, Thompson GB, Grant CS & van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist 1999 9 77-80.
101. Noshiro T, Shimizu K, Watanabe T, Akama H, Shibukawa S, Miura W et al. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. American Journal of Hypertension 2000 13 35-43.
102. Miyajima A, Nakashima J, Baba S, Tachibana M, Nakamura K & Murai M. Clinical experience with incidentally discovered pheochromocytoma. Journal of Urology 1997 157 1566-1568.
103. Reincke M, Winkelmann W, Jaursch-Hancke C, Kaulen D, Nieke J, Ollenschlager G et al. Diagnostik und Therapie asymptomatischer Nebennierentumoren. Deutsche Medizinische Wochenschrift 1989 144 861-865.
104. Jockenhovel F, Kuck W, Hauffa B, Reinhardt W, Beaker G, Lederbogen S et al. Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas). Journal of Endocrinological Investigation 1992 15 331-337.
105. Courtade A, Carnaille B, Ernst O, Renan CA, L'Herminé C & Proye C. Outcome of incidental adrenal masses not operated on: 44 cases over 7 years. European Journal of Surgery 1997 163 315.
106. Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB & Ilstrup DM. Can adrenal incidentalomas be safely observed? World Journal of Surgery 1998 22 599-603.
107. Siren J, Tervahartiala P, Sivula A & Haapiainen R. Natural course of adrenal incidentalomas: seven-year follow-up study. World Journal of Surgery 2000 24 579-582.
108. Libè R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P & Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. European Journal of Endocrinology 2002 147 489-494.
109. Hofle G, Gasser RW, Lhotta K, Janetschek G, Kreczy A & Finkenstedt G. Adrenocortical carcinoma evolving after diagnosis of preclinical Cushing's syndrome in an adrenal incidentaloma: a case report. Hormone Research 1998 50 237-242.
110. Barzon L, Zucchetta P, Boscaro M, Marzola MC, Bui F & Fallo F. Scintigraphic patterns of adrenocortical carcinomas: morphofunctional correlates. European Journal of Endocrinology 2001 145 743-748.
111. Favia G, Lumachi F & D'Amico DF. Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World Journal of Surgery 2001 25 735-738.
112. Kasperlik-Zaluska AA, Migdalska B & Makowska A. Incidentally found adrenocrtical carcinoma. A study of 21 patients. European Journal of Cancer 1998 34 1721-1724.
113. Vassilopoulou-Sellin R & Schultz PN. Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 2001 92 1113-1121.
114. Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. New England Journal of Medicine 1990 322 1195-1201.
115. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeon Study Group. World Journal of Surgery 2001 25 891-897.
116. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A & Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 1999 84 520-526.
117. Fernandez-Real JM, Richart Engel W, Simò R, Salinas I & Webb SM. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Clinical Endocrinology 1998 49 53-61.
118. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism 2002 87 998-1003.
119. Tauchmanovà L, Rossi R, Nuzzo V, del Puente A, Esposito-del Puente A, Pizzi C et al. Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. European Journal of Endocrinology 2001 145 241-247.
120. Sartorio A, Conti A, Ferrero S, Giambona S, Re T, Passini E et al. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. European Journal of Endocrinology 1998 138 146-152.
121. Chiodini I, Torlontano M, Carnevale V, Guglielmi G, Cammisa M, Trischitta V et al. Bone loss rate in adrenal incidentalomas: a longitudinal study. Journal of Clinical Endocrinology and Metabolism 2001 86 5337-5341.
122. Chiodini I, Tauchmanova L, Torlontano M, Battista C, Guglielmi G, Cammisa M et al. Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2002 87 4869-4871.
123. Garrapa GM, Pantanetti P, Arnaldi G, Mantero F & Faloia E. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 5301-5306.
124. Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V et al. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clinical Endocrinology 1998 48 627-633.
125. Reincke M, Fasnachat M, Vath S, Mora P & Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocrine Research 1996 22 757-761.
126. Tauchmanova L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2002 87 4872-4878.
127. Gross MD, Shapiro B, Francis IR, Glazer GM, Bree RL, Arcomano MA et al. Scintigraphic evaluation of clinically silent adrenal masses. Journal of Nuclear Medicine 1994 35 1145-1152.